Abstract:Gene dosage variations occur in many diseases. In cancer, deletions and copy number increases contribute to alterations in the expression of tumour-suppressor genes and oncogenes, respectively. Developmental abnormalities, such as Down, Prader Willi, Angelman and Cri du Chat syndromes, result from gain or loss of one copy of a chromosome or chromosomal region. Thus, detection and mapping of copy number abnormalities provide an approach for associating aberrations with disease phenotype and for localizing critical genes. Comparative genomic hybridization3(CGH) was developed for genome-wide analysis of DNA sequence copy number in a single experiment. In CGH, differentially labelled total genomic DNA from a 'test' and a 'reference' cell population are cohybridized to normal metaphase chromosomes, using blocking DNA to suppress signals from repetitive sequences. The resulting ratio of the fluorescence intensities at a location on the 'cytogenetic map', provided by the chromosomes, is approximately proportional to the ratio of the copy numbers of the corresponding DNA sequences in the test and reference genomes. CGH has been broadly applied to human and mouse malignancies. The use of metaphase chromosomes, however, limits detection of events involving small regions (of less than 20 Mb) of the genome, resolution of closely spaced aberrations and linking ratio changes to genomic/genetic markers. Therefore, more laborious locus-by-locus techniques have been required for higher resolution studies2,3,4,5. Hybridization to an array of mapped sequences instead of metaphase chromosomes could overcome the limitations of conventional CGH (ref. 6) if adequate performance could be achieved. Copy number would be related to the test/reference fluorescence ratio on the array targets, and genomic resolution could be determined by the map distance between the targets, or by the length of the cloned DNA segments. We describe here our implementation of array CGH. We demonstrate its ability to measure copy number with high precision in the human genome, and to analyse clinical specimens by obtaining new information on chromosome 20 aberrations in breast cancer.

Detection of Gene Copy Number Change in Array CGH Data

Exploiting Noise in Array CGH Data to Improve Detection of DNA Copy Number Change.

Accuracy Of Cnv Detection From Gwas Data

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

Sequential Model Selection-Based Segmentation to Detect Dna Copy Number Variation

Bayesian Random Segmentation Models to Identify Shared Copy Number Aberrations for Array CGH Data

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Oligonucleotide Microarrays for Clinical Diagnosis of Copy Number Variation

Statistical Methods for Detecting Genomic Alterations Through Array-Based Comparative Genomic Hybridization (CGH).

CGHTRIMMER: Discretizing noisy Array CGH Data

Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer.

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization

A Cluster-Based Approach for the Discovery of Copy Number Variations from Next-Generation Sequencing Data

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples

Copy-number-variation and copy-number-alteration region detection by cumulative plots

Functional Genomic Analysis of Chromosomal Aberrations in a Compendium of 8000 Cancer Genomes

Combinatorial Detection Algorithm for Copy Number Variations Using High-throughput Sequencing Reads

Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.

A Remark on Copy Number Variation Detection Methods

Enhanced Bayesian detection for copy number alterations from next-generation sequencing data.